Clinical phenotype of Parkinson’s disease with a homozygous PRKN p.Cys441Arg mutation

Shen Yang Lim*, Azlina Ahmad-Annuar, Katja Lohmann, Ai Huey Tan, Yi Wen Tay, Jia Lun Lim, Kai Bin Lim, Lei Cheng Lit, Peter Bauer, Arndt Rolfs, Christine Klein

*Corresponding author for this work


We describe the clinical features of a Malaysian woman with Parkinson’s disease (PD) who carried the PRKN p.Cys441Arg mutation in the homozygous state. She had a fairly “classic” clinical presentation for PARK-Parkin, including juvenile onset and a clear response to dopaminergic medication complicated by motor fluctuations and dyskinesias. She had a substantial benefit with apomorphine infusion treatment, which to our knowledge has not been reported for PARK-Parkin. Our report contributes to the very scarce literature on monogenic causes of PD in the Malaysian population, and highlights an alternative treatment option to oral dopaminergic medication or deep brain stimulation surgery.

Original languageEnglish
JournalNeurology Asia
Issue number1
Pages (from-to)161-166
Number of pages6
Publication statusPublished - 2021


Dive into the research topics of 'Clinical phenotype of Parkinson’s disease with a homozygous PRKN p.Cys441Arg mutation'. Together they form a unique fingerprint.

Cite this